Documenti fondamentali

Visualizza tutta la documentazione

Vai a

BP809

Cisplatin

Name: Cisplatin
Brand: SIAL

British Pharmacopoeia (BP) Reference Standard

Sinonimo/i:

cis-Diammineplatinum(II) dichloride, cis-Dichlorodiammine platinum(II), cis-Platinum(II) diammine dichloride, Cisplatin

Autenticati per visualizzare i prezzi organizzativi e contrattuali.

Scegli un formato

Cambia visualizzazione

Taglio della confezione	SKU	Disponibilità	Prezzo

Informazioni su questo articolo

Formula condensata:

Pt(NH₃)₂Cl₂

Numero CAS:

15663-27-1

Peso molecolare:

300.05

UNSPSC Code:

41116107

NACRES:

NA.24

EC Number:

239-733-8

MDL number:

MFCD00011623

Prezzi e disponibilità al momento non sono disponibili

Servizio Tecnico

Hai bisogno di aiuto? Il nostro team di scienziati qualificati è a tua disposizione.

Permettici di aiutarti

Proprietà

grade

pharmaceutical primary standard

API family

cisplatin

form

solid

shelf life

limited shelf life, expiry date on the label

manufacturer/tradename

mp

270 °C (lit.)

application(s)

pharmaceutical
pharmaceutical small molecule

format

neat

storage temp.

2-8°C

SMILES string

N.N.Cl[Pt]Cl

InChI

1S/2ClH.2H3N.Pt/h2*1H;2*1H3;/q;;;;+2/p-2

InChI key

LXZZYRPGZAFOLE-UHFFFAOYSA-L

Descrizione

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Cisplatin BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:

Cisplatin Injection

Biochem/physiol Actions

Potent platinum-based antineoplastic agent. Forms cytotoxic adducts with the DNA dinucleotide d(pGpG), inducing intrastrand cross-links.

Packaging

Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

Other Notes

Sales restrictions may apply.

Confronta articoli simili

Visualizza il confronto per intero

Mostra le differenze

1 of 1

Questo articolo	1134357	PHR1624	232120
BP809 Cisplatin	USP 1134357 Cisplatin	Supelco PHR1624 Cisplatin	Sigma-Aldrich 232120 Cisplatin
manufacturer/tradename BP	manufacturer/tradename USP	manufacturer/tradename -	manufacturer/tradename Calbiochem^®
grade pharmaceutical primary standard	grade pharmaceutical primary standard	grade certified reference material, pharmaceutical secondary standard	grade -
form solid	form -	form -	form solid
application(s) pharmaceutical pharmaceutical small molecule	application(s) pharmaceutical (small molecule)	application(s) pharmaceutical (small molecule)	application(s) -
format neat	format neat	format neat	format -
shelf life limited shelf life, expiry date on the label	shelf life -	shelf life -	shelf life -

Still not finding the right product?

Explore all of our products under Cisplatin

pictograms

GHS06,GHS08

signalword

Danger

target_organs

Respiratory system

Classe di stoccaggio

6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

hcodes

H300,H315,H317,H319,H334,H335,H340,H350,H360FD

pcodes

P202 - P261 - P280 - P301 + P310 - P302 + P352 - P305 + P351 + P338

Hazard Classifications

Acute Tox. 2 Oral - Carc. 1B - Eye Irrit. 2 - Muta. 1B - Repr. 1B - Resp. Sens. 1 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3

Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documenti section.

Se ti serve aiuto, non esitare a contattarci Servizio Clienti

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

Interference with SMO increases chemotherapy drug sensitivity of A2780/DDP cells by inhibiting the Hh/Gli signaling pathway.

Shihong Ma et al.

Journal of cellular biochemistry, 121(5-6), 3256-3265 (2020-01-07)

Aberrant activation of the Hedgehog (Hh)/Gli pathway contributes to the tumorigenesis of several human cancers, including ovarian cancers. We investigated the function of SMO on cell growth, drug resistance, and invasive ability in A2780/DDP cells. Moreover, we also tested the

Myricitrin protects against cisplatin-induced kidney injury by eliminating excessive reactive oxygen species.

Ruiqian Li et al.

International urology and nephrology, 52(1), 187-196 (2019-12-13)

Cisplatin could result in a wide range of kidney injuries. During the pathogenetic process, the excessive generation of reactive oxygen species (ROS) induced by cisplatin has been regarded as the initial and critical role, by which DNA damage and cell

The calcium pump PMCA4 prevents epithelial-mesenchymal transition by inhibiting NFATc1-ZEB1 pathway in gastric cancer.

Teng Wang et al.

Biochimica et biophysica acta. Molecular cell research, 1867(12), 118833-118833 (2020-08-30)

Epithelial-mesenchymal transition (EMT) is considered as the key mechanism involved in cancer metastasis. Several studies showed that various cell membrane calcium channels play different roles in cancer metastasis. In the present study, the potential role of ATPase plasma membrane Ca2+

Visualizza tutti i documenti correlati

Numero articolo commerciale globale

SKU	GTIN
BP809	04061835275700

Questions

Reviews

No rating value